- Delayed recurrence of hepatocellular carcinoma after liver transplantation: case series
-
Wong TH, Ho CM, Hsiao CY, Wu YM, Ho MC, Lee PH, Hu RH
- KMID: 2521341
- Korean J Transplant.
- 2021 Oct;35(Supple 1):S135.
- doi: 10.4285/ATW2021.OP-1051
Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and liver transplant is the definite curative treatment option. However, 15%–20% of recipients will experience HCC recurrence... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival after treatable hepatocellular carcinoma recurrence in liver recipients: a nationwide cohort analysis
-
Ho CM, Lee CH, Lee MC, Zhang JF, Chen CH, Wang JY, Hu RH, Lee PH
- KMID: 2521232
- Korean J Transplant.
- 2021 Oct;35(Supple 1):S21.
- doi: 10.4285/ATW2021.OP-1022
Background: Survival after post-transplant recurrence of hepatocellular carcinoma (HCC) is dismal, and almost all treatments for recurrent HCC are off-labeled, without an extensive large-scale analysis. We aimed to delineate their... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure
-
Ho CM, Chen YH, Chien CS, Ho SL, Chen HL, Hu RH, Lee PH
- KMID: 2503886
- Korean J Transplant.
- 2020 Jun;34(2):100-108.
- doi: 10.4285/kjt.2020.34.2.100
Background: Cell therapy is considered a potential alternative to liver transplantation in acute liver failure (ALF). We aimed to evaluate the add-on therapeutic benefit of hepatocyte and mesenchymal stem cell... -
- CITED
-
- Close
- SHARE
-
- Close
